Shu Lin
Program: Cancer Biology
Current advisor: Stephen Oh, MD, PhD
Undergraduate university: Vanderbilt University
Research summary
We are targeting LGALS1 or galectin-1 as a novel therapeutic target in the treatment of myeloproliferative neoplasm (MPN)
Graduate publications
He F, Laranjeira AB, Kong T, Lin S, Ashworth KJ, Liu A, Lasky NM, Fisher DA, Cox MJ, Fulbright MC, Antunes-Heck L, Yu L, Brakhane M, Gao B, Sykes SM, D’Alessandro A, Di Paola J, Oh ST. 2024 Multiomic profiling reveals metabolic alterations mediating aberrant platelet activity and inflammation in myeloproliferative neoplasms. J Clin Invest, 343(3):e172256.